Kazutaka Aoki

1.3k total citations
48 papers, 1.0k citations indexed

About

Kazutaka Aoki is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Kazutaka Aoki has authored 48 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Endocrinology, Diabetes and Metabolism, 16 papers in Surgery and 12 papers in Molecular Biology. Recurrent topics in Kazutaka Aoki's work include Diabetes Treatment and Management (27 papers), Diabetes Management and Research (18 papers) and Pancreatic function and diabetes (9 papers). Kazutaka Aoki is often cited by papers focused on Diabetes Treatment and Management (27 papers), Diabetes Management and Research (18 papers) and Pancreatic function and diabetes (9 papers). Kazutaka Aoki collaborates with scholars based in Japan. Kazutaka Aoki's co-authors include Yasuo Terauchi, Yu Togashi, Yuzuru Ito, Hisahiko Sekihara, Hiroshi Kamiyama, Jun Shirakawa, Koichiro Sato, Akinobu Nakamura, Shinobu Satoh and Kikuko Amo and has published in prestigious journals such as PLoS ONE, Diabetes and Endocrinology.

In The Last Decade

Kazutaka Aoki

48 papers receiving 1.0k citations

Peers

Kazutaka Aoki
Chris Baker Canada
Ping Han China
Cecilia Morgantini Canada
Sébastien Bolze France
Kenji Arakawa Japan
V. Pechtner United States
Lisa Federico Canada
Gian Piero Carnevale Schianca Italy
Ernst J. Schaefer United States
Kacey J. Prentice Canada
Chris Baker Canada
Kazutaka Aoki
Citations per year, relative to Kazutaka Aoki Kazutaka Aoki (= 1×) peers Chris Baker

Countries citing papers authored by Kazutaka Aoki

Since Specialization
Citations

This map shows the geographic impact of Kazutaka Aoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazutaka Aoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazutaka Aoki more than expected).

Fields of papers citing papers by Kazutaka Aoki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazutaka Aoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazutaka Aoki. The network helps show where Kazutaka Aoki may publish in the future.

Co-authorship network of co-authors of Kazutaka Aoki

This figure shows the co-authorship network connecting the top 25 collaborators of Kazutaka Aoki. A scholar is included among the top collaborators of Kazutaka Aoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazutaka Aoki. Kazutaka Aoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aoki, Kazutaka, et al.. (2020). Comparison of Lipid-Lowering Effects of Anagliptin and Miglitol in Patients With Type 2 Diabetes: A Randomized Trial. Journal of Clinical Medicine Research. 12(2). 73–78. 5 indexed citations
2.
Kondo, Yoshinobu, Kazutaka Aoki, Jun Shirakawa, et al.. (2018). A Randomized Controlled Trial of a Mini Low-Carbohydrate Diet and an Energy-Controlled Diet Among Japanese Patients With Type 2 Diabetes. Journal of Clinical Medicine Research. 10(3). 182–188. 10 indexed citations
3.
Aoki, Kazutaka & Yasuo Terauchi. (2018). Effect of Dehydroepiandrosterone (DHEA) on Diabetes Mellitus and Obesity. Vitamins and hormones. 108. 355–365. 35 indexed citations
4.
Shibata, Eriko, Kazutaka Aoki, Kazuki Tajima, Masataka Taguri, & Yasuo Terauchi. (2016). Comparison of efficacy and safety of taking miglitol dissolved in water during a meal and taking a miglitol tablet just before a meal in patients with type 2 diabetes. Expert Opinion on Pharmacotherapy. 17(7). 889–894. 6 indexed citations
5.
Aoki, Kazutaka, Kazuki Tajima, Masataka Taguri, & Yasuo Terauchi. (2016). Effect of dehydroepiandrosterone (DHEA) on Akt and protein kinase C zeta (PKCζ) phosphorylation in different tissues of C57BL6, insulin receptor substrate (IRS)1−/−, and IRS2−/− male mice fed a high-fat diet. The Journal of Steroid Biochemistry and Molecular Biology. 159. 110–120. 10 indexed citations
6.
7.
Kamiyama, Hiroshi, et al.. (2014). Effect of repaglinide, administered two or three times daily for 3 months, on glycaemic control in Japanese patients with type 2 diabetes mellitus. Journal of International Medical Research. 42(5). 1150–1160. 1 indexed citations
8.
Aoki, Kazutaka, Masahiro Takihata, Yuzuru Ito, et al.. (2013). Glycemic control after addition of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes showing inadequate response to thrice-a-day treatment with α-glucosidase inhibitors. Expert Opinion on Pharmacotherapy. 14(9). 1111–1118. 5 indexed citations
9.
Tajima, Kazuki, Jun Shirakawa, Yu Togashi, et al.. (2013). AMPK Is Involved in the Regulation of Incretin Receptors Expression in Pancreatic Islets under a Low Glucose Concentration. PLoS ONE. 8(5). e64633–e64633. 6 indexed citations
10.
Takihata, Masahiro, Akinobu Nakamura, Kazutaka Aoki, et al.. (2013). Comparison of intragastric balloon therapy and intensive lifestyle modification therapy with respect to weight reduction and abdominal fat distribution in super-obese Japanese patients. Obesity Research & Clinical Practice. 8(4). e331–e338. 22 indexed citations
11.
Aoki, Kazutaka, et al.. (2013). Mosapride citrate, a 5-HT₄ receptor agonist, increased the plasma active and total glucagon-like peptide-1 levels in non-diabetic men.. PubMed. 60(4). 493–9. 10 indexed citations
12.
Aoki, Kazutaka & Yasuo Terauchi. (2012). Effect of Acarbose Therapy Once or Twice a Day on Glycemic Control in Japanese Patients with Type 2 Diabetes. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 43(1). 17–20. 4 indexed citations
13.
14.
Aoki, Kazutaka, Kaori Kikuchi, Akinobu Nakamura, et al.. (2010). Self-Injection of Insulin Using Appropriate Supportive Devices in Handicapped Subjects with Diabetes. Diabetes Technology & Therapeutics. 12(6). 483–490. 4 indexed citations
15.
Aoki, Kazutaka, Tomoyuki Iwasaki, Akinobu Nakamura, et al.. (2010). Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet. Metabolism. 60(5). 617–628. 56 indexed citations
16.
Kawasaki, Satsuki, Kazutaka Aoki, Osamu Hasegawa, et al.. (2007). Sonographic evaluation of visceral fat by measuring para‐ and perirenal fat. Journal of Clinical Ultrasound. 36(3). 129–133. 54 indexed citations
17.
Aoki, Kazutaka, Akinobu Nakamura, Satoshi Ito, et al.. (2007). Administration of miglitol until 30min after the start of a meal is effective in type 2 diabetic patients. Diabetes Research and Clinical Practice. 78(1). 30–33. 26 indexed citations
18.
Aoki, Kazutaka, Hideki Taniguchi, Yuzuru Ito, et al.. (2004). Dehydroepiandrosterone decreases elevated hepatic glucose production in C57BL/KsJ-db/db mice. Life Sciences. 74(25). 3075–3084. 19 indexed citations
19.
Aoki, Kazutaka, Masato Homma, Toshihiko Hirano, et al.. (2001). mRNA and enzyme activity of hepatic 11β-hydroxysteroid dehydrogenase type 1 are elevated in C57BL/KsJ-db/db mice. Life Sciences. 69(21). 2543–2549. 17 indexed citations
20.
Mukasa, Koji, Kazutaka Aoki, Jun Okamura, et al.. (1998). Dehydroepiandrosterone (DHEA) ameliorates the insulin sensitivity in older rats. The Journal of Steroid Biochemistry and Molecular Biology. 67(4). 355–358. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chris Baker Breakdown of academic impact, for papers by Ping Han Breakdown of academic impact, for papers by Cecilia Morgantini Breakdown of academic impact, for papers by Sébastien Bolze Breakdown of academic impact, for papers by Kenji Arakawa Breakdown of academic impact, for papers by V. Pechtner Breakdown of academic impact, for papers by Lisa Federico Breakdown of academic impact, for papers by Gian Piero Carnevale Schianca Breakdown of academic impact, for papers by Ernst J. Schaefer Breakdown of academic impact, for papers by Kacey J. Prentice
Rankless by CCL
2026